Answers are grounded in this paper and cite their sources.
Renal and hepatic interactions are highly complex with increasing evidence for an important relationship between AKI and hepatic metabolism. Current recommended dosing regimens are inadequate for AKI patients and much greater understanding of the interaction between the kidney and liver is required. More extensive therapeutic drug monitoring may be required to optimize drug regimens.
No takes yet. Share an insight, caveat, or question.
Philips et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: